Brain cancer prediction has emerged as a critical focus in improving outcomes for young patients, particularly those battling pediatric brain cancer.Recent advancements in artificial intelligence (AI) are revolutionizing the way we assess the risk of glioma recurrence in children who have undergone treatment.